https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.943066/full
Frontiers | Immune-related RNA signature predicts outcome of PD-1 inhibitor-combined GEMCIS therapy...
AbstractBackground: Immune checkpoint inhibitors (ICIs) combined chemotherapy in advanced intrahepatic cholangiocarcinoma have been proved more efficacy in a...